Lv65
2970 积分 2024-08-19 加入
Serum DUPAN-2 could be an Alternative Biological Marker for CA19-9 Non-secretors with Pancreatic Cancer
5个月前
已完结
全胰十二指肠切除术治疗胰腺癌手术要点及术后康复管理情况
6个月前
已完结
胰腺癌吉西他滨耐药细胞株的建立及其生物学行为分析
6个月前
已完结
肿瘤糖类抗原19-9阴性胰腺癌患者预后的影响因素分析
6个月前
已完结
Lewis antigen‑negative pancreatic cancer: An aggressive subgroup
6个月前
已完结
CD44 Identified as a Diagnostic Biomarker for Highly Malignant CA19-9 Negative Pancreatic Cancer
6个月前
已完结
DUPAN-2 as a Risk Factor of Early Recurrence After Curative Pancreatectomy for Patients With Pancreatic Ductal Adenocarcinoma
6个月前
已完结
EGFR is a potential therapeutic target for highly glycosylated and aggressive pancreatic neuroendocrine neoplasms
7个月前
已完结
Adjuvant Chemotherapy After Resection of Localized Pancreatic Adenocarcinoma Following Preoperative FOLFIRINOX
7个月前
已完结
胰腺癌诊治指南(2014)
7个月前
已关闭
皖公网安备34019202002308
